In honor of Atrial Fibrillation (Afib) Awareness Month, Team AFib would like to invite you to our second webinar, “AFib CARE: Creating A Role for Effective Teams”, taking place at 1:00 p.m. ET on Wednesday, September 14 and hosted by StopAfib.org. To learn more, see: Join Team AFib’s Atrial Fibrillation Webinar, “AFib CARE: Creating A …
Read More
In her first regular Patient Perspective column, which appears in the August issue of EP Lab Digest, StopAfib.org founder Mellanie True Hills explores a concern in the atrial fibrillation patient community that staying in afib long term could be a "death sentence." In addition, she talks about the upcoming National Atrial Fibrillation Awareness Month, which …
Read More
StopAfib.org would like to applaud and thank Sen. Michael Crapo [R-ID], Sen. Robert Casey [D-PA], Sen. Daniel Inouye [D-HI], Sen. Daniel Akaka [D-HI], Sen. Marco Rubio [R-FL], and Sen. Patrick Toomey [R-PA] for introducing and passing the Atrial Fibrillation Resolution (S. Res. 243), which promotes increased awareness, diagnosis, and treatment of atrial fibrillation. To learn …
Read More
As a patient, you probably see lots of hype-filled reports about various drugs. After a drug is approved, there’s an inevitable blitz of negative publicity which often scares people away from important new solutions that could help them. There has been so much news lately about Multaq (dronedarone), the drug designed to provide the benefits …
Read More
We have just gotten word that the US Senate has passed the Atrial Fibrillation Resolution (S. Res. 243) by unanimous consent. The resolution, introduced by Sen. Crapo and co-introducers Sen. Casey, Sen. Inouye, Sen. Akaka, Sen. Rubio, and Sen. Toomey, promotes increased awareness, diagnosis, and treatment of atrial fibrillation. More information as it is available.
Read More
The US FDA has just announced that on September 8, 2011, the FDA Cardiovascular and Renal Drugs Advisory Committee will meet to review whether to recommend approval of rivaroxaban (brand name Xarelto), an alternative to warfarin, for stroke prevention in atrial fibrillation. In this recent video interview, Dr. Elaine Hylek, a leading anticoagulant authority, discussed …
Read More
Recently StopAfib.org partnered with the Cleveland Clinic to give you a rare opportunity to chat live with three of their atrial fibrillation experts, Dr. Bruce Lindsay, Dr. Marc Gillinov, and Dr. David Van Wagoner who were joined by StopAfib.org founder Mellanie True Hills. The transcript of our afib community chat with these atrial fibrillation experts …
Read More
While catheter ablation has been proven more effective at stopping atrial fibrillation than antiarrhythmic drugs, pulmonary veins may reconnect and atrial fibrillation may return, causing the catheter ablation to fail. At the recent Heart Rhythm Society meeting, Dr. Vivek Reddy, Director of Cardiac Arrhythmia Services at Mt. Sinai Hospital in New York City, presented clinical …
Read More
House Resolution 295 has just been introduced by StopAfib.org's home district representative, Congresswoman Kay Granger (R-TX). We would like to thank Representative Granger for her support of the atrial fibrillation community. The AF Resolution encourages promotion of afib awareness, diagnosis, and treatment. To move the resolution out of committee and to the House floor for …
Read More
Data presented at the recent 2011 Heart Rhythm Society meeting in San Francisco regarding the effectiveness of catheter ablation for treatment of persistent atrial fibrillation suggests that multiple procedures may be needed. Dr. Thomas Rostock presented data on 395 patients (261 with persistent atrial fibrillation and 134 with longstanding persistent afib) who had stepwise ablation …
Read More